Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

PHASE2TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 10, 2011

Primary Completion Date

May 13, 2014

Study Completion Date

May 13, 2014

Conditions
Transfusional Iron OverloadBeta-Thalassemia
Interventions
DRUG

SPD602

Trial Locations (9)

19104

Children's Hospital of Philadelphia, Philadelphia

35100

Ege University Hospital, Izmir

02115

Children's Hospital Boston, Boston

Unknown

Toronto Sick Kids Hospital, Toronto

Centro della Microcitemia e delle Anemie Congenite, Genoa

Thalassemia Center San Luigi Hospital, Orbassano

American University of Beirut Medical Center, Beirut

Chronic Care Center, Beirut

09121

Ospedale Regionale Mecrocitemie, Cagliari

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT01363908 - Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload | Biotech Hunter | Biotech Hunter